Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis

Haemophilia. 2019 May;25(3):e215-e218. doi: 10.1111/hae.13733. Epub 2019 Mar 13.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cross-Sectional Studies
  • Drug Compounding
  • Factor VIII / chemistry
  • Factor VIII / pharmacokinetics*
  • Factor VIII / pharmacology*
  • Female
  • Hemophilia A / complications*
  • Hemophilia A / metabolism
  • Hemorrhage / complications*
  • Hemorrhage / prevention & control*
  • Humans
  • Middle Aged
  • Sucrose / chemistry*
  • Treatment Outcome
  • Young Adult

Substances

  • Sucrose
  • F8 protein, human
  • Factor VIII

Grants and funding